- Methodology article
- Open Access
Efficient activation of gene expression using a heat-shock inducible Gal4/Vp16-UAS system in medaka
BMC Biotechnologyvolume 4, Article number: 26 (2004)
Genetic interference by DNA, mRNA or morpholino injection is a widely used approach to study gene function in developmental biology. However, the lack of temporal control over the activity of interfering molecules often hampers investigation of gene function required during later stages of embryogenesis. To elucidate the roles of genes during embryogenesis a precise temporal control of transgene expression levels in the developing organism is on demand.
We have generated a transgenic Gal4/Vp16 activator line that is heat-shock inducible, thereby providing a tool to drive the expression of specific effector genes via Gal4/Vp16. Merging the Gal4/Vp16-UAS system with the I-SceI meganuclease and the Sleeping Beauty transposon system allows inducible gene expression in an entirely uniform manner without the need to generate transgenic effector lines. Combination of this system with fluorescent protein reporters furthermore facilitates the direct visualization of transgene expressing cells in live embryos.
The combinatorial properties of this expression system provide a powerful tool for the analysis of gene function during embryonic and larval development in fish by ectopic expression of gene products.
The most widely used strategies to investigate the function of genes in medaka (Oryzias latipes) are the analyses of mutants, miss-expression of wild type genes or their variants by mRNA injection and gene specific translational inhibition by morpholino injections [1–3]. However, the phenotype of a given mutation mainly reflects the first temporal function of the affected gene in embryonic development, obscuring possible later functions. Similarly, mRNA and morpholinos exert their functions immediately following injection, providing information only on the early role of the gene of interest. A detailed analysis of gene function in a given process can thus be a difficult task. The Gal4/UAS system provides an alternative and more specific strategy to analyze specific functions of a gene [4, 5]. The direct application of the Drosophila Gal4-UAS approach, by the generation of transgenic lines, has been established successfully in zebrafish [6, 7]. However, the generation of different transgenic activator and effector lines may be a time- and space-consuming task, and expression levels in these transgenic lines are weak, probably due to a limited transactivation potential of Gal4 in fish. Gal4/Vp16, a fusion of the yeast Gal4 DNA-binding domain with the strong Vp16 transactivation domain of the herpes simplex virus  can be used to enhance transactivation efficacy. Yet, strong transcriptional activators can cause unspecific promoter squelching  resulting in retardation of embryogenesis . Nonetheless, the Gal4/Vp16-UAS system has been used in zebrafish in transient approaches resulting in mosaic, but easily detectable transgene expression .
We have applied the Gal4/Vp16-UAS system for transient transactivation in a heat-shock inducible transgenic Gal4/Vp16 activator line. Generation of transgenic medaka lines, which allow the induction of the Gal4/Vp16 activator to 'physiological' (i.e. non-toxic) levels was achieved by using a 5' truncated version of the zebrafish heat-shock promoter HSP70 . Using a heat-shock promoter to drive expression of the Gal4/Vp16 activator allows tight temporal control of activator and effector (reporter) gene expression. To trace transgene expression in cells of living embryos we have used the cyan fluorescent and yellow fluorescent proteins (CFP, YFP). Combination with the meganuclease (MN) transgenesis system  and the direct-inverted repeats (IR/DR) of the Sleeping Beauty (SB) transposon system  yielded high numbers of transgene expressing cells. Thus, in contrast to the entirely mosaic nature of a transient approach reported thus far, the combined use of a transgenic activator line with systems enhancing even DNA distribution or early integration allows uniform expression of injected effector genes upon induction by heat-shock treatment without an immediate need to generate transgenic UAS lines.
Results and discussion
Generation of a heat-shock inducible transgenic Gal4/Vp16 activator line (pCG6.0WCS/T)
DNA injection leading to mosaic expression in G0 allows in vivo tracing of transgene-expressing cells and observation of effects exerted by the transgene through application of fluorescent markers . However, elucidation of biological questions sometimes requires ubiquitous expression of transgenes in a temporally controlled manner. While the MN protocol strongly reduces mosaicism, it does so only in a fraction of injected embryos (, Fig. 1F,1G,1H,1I,1J,1K and Table 1). This can be improved by the use of transgenic animals providing inducible and sufficient expression in all cells.
The idea is to combine stable heat-shock inducible expression of the Gal4/Vp16 activator with transient expression of effector genes upon microinjection. The effector constructs are uniformly distributed in the entire embryo due to the presence of the SB direct-inverted repeats . We have designed two activator/reporter vectors containing Gal4/Vp16 under control of a 1.5 kb fragment of the zebrafish (zf) HSP70 promoter (pCG5.0WCS) or a 0.6 kb 5' truncated fragment of zfHSP70, respectively (pCG6.0WCS). Both vectors contain CFP downstream of several UAS elements as an internal reporter. The IR/DRs of SB and two I-SceI meganuclease sites flank this entire expression cassette (Fig. 1A). The internal reporter provides a direct read-out for activator expression. A third vector (pCG3.0Y), containing YFP downstream of several UAS elements and flanked by IR/DRs, was designed as an independent reporter (Fig. 1A).
It has been shown that the Gal4/Vp16 activator can interfere with general transcription by titrating the basal transcription machinery . We observed developmental retardation and malformation in all embryos injected with Gal4/Vp16 driven by ubiquitous promoters. Similarly, co-injection of high concentrations of Gal4/Vp16 mRNA (50 ng/μl) with pCG5.0WCS always resulted in developmental malformations (not shown). However, DNA co-injections did not affect embryonic development in transient experiments when the HSP70 promoter was used to control Gal4/Vp16 expression (Fig. 1B,1B',1F,1G,1H,1I,1J,1K). Moreover, co-injections of low concentrations of Gal4/Vp16 mRNA (3.5 ng/μl) with the activator/reporter construct pCG5.0WCS also showed no effects on embryogenesis (Fig. 1C,1C'), suggesting that the toxicity of the activator depends on the expression level.
The truncated version of the zfHSP70 promoter fragment used in the activator/reporter construct pCG6.0WCS showed a moderate activation upon heat-shock treatment. This allowed adjusting the induction levels by varying the heat-shock duration. A transgenic medaka line was established (by co-injection of circular vector pCG6.0WCS with MN) in which expression levels directly correlated with the heat-shock duration. Extended heat-shocks resulted in very high expression levels, but also caused retardation phenotypes due to the strong transactivation potential of the Gal4/Vp16 fusion protein. Comparable phenotypes were not observed in heat-shock treated wild type embryos. Depending on the developmental stage at the time of induction, the duration of heat-shock treatment was adjusted to induce Gal4/Vp16 and reporter expression without interfering with embryonic development. Induction periods ranged from one minute of heat-shock at 37°C at early stages (~st16/21hpf) to 10 minutes at later stages (~st22/38hpf). On top of uniform CFP expression in the entire embryo and yolk upon heat-shock, some regions of the embryo showed additional responsiveness of the reporter (Fig. 1E,1E').
Microinjection experiments and RT-PCR revealed that reporter gene (CFP) expression in transgenic fish is mediated by Gal4/Vp16. Offspring of pCG6.0-WCS/T transgenic fish was injected with Gal4/Vp16 mRNA (3.5 ng/μl) at the one-cell stage without heat-shock treatment. Injected embryos exhibited uniform expression of CFP shortly after the onset of zygotic transcription at the mid-blastula transition , indicating that CFP expression was induced in response to Gal4/Vp16 (Fig. 1D,1D').
We applied RT-PCR for the dose/response analysis of activator and reporter mRNA (Fig. 2A). Transcripts of Gal4/Vp16 were detectable already 10 minutes after a heat-shock of 90 seconds at 37°C. Following a steady increase until about three hours after induction, Gal4/Vp16 messages were degraded between five and ten hours to undetectable levels after twenty hours. CFP mRNA was first detected after two hours and transcript levels were still increasing after 25 h. This indicates that the transcription of the reporter CFP is controlled by Gal4/Vp16 protein and that active Gal4/Vp16 is still present when the amount of its transcripts already dropped below detectable levels (Fig. 2A).
Activation of an independent reporter upon injection into the transgenic activator line pCG6.0WCS/T
We tested the Gal4/Vp16 activator line pCG6.0WCS/T as a tool to induce expression of an independent reporter upon injection of plasmid DNA (pCG3.0Y). Transgenic embryos were injected with different concentrations of the reporter pCG3.0Y (5–150 ng/μl). Injected embryos were subjected to heat-shock treatment at different developmental stages for various periods of time, kept at 28°C thereafter and monitored for activator and effector expression during the following days. Due to the SB IR/DRs flanking the expression cassette, the independent reporter was distributed equally in the entire embryo resulting in ubiquitous expression of YFP, entirely co-localizing with the internal reporter (CFP). Additional mosaic clones of cells expressing YFP at higher levels presumably reflect higher plasmid concentrations in these cells (Fig. 2B,2C,2D,2E,2F,2G,2H,2I,2J and Table 1). However, YFP expression levels appeared relatively independent from the DNA concentration, but were directly correlated to the expression levels of the activator or internal reporter, respectively.
Here we show that the Gal4/Vp16-UAS transactivation system can be efficiently used in medaka. By using fluorescent proteins as internal or independent reporter, cells co-expressing the activator and the gene of interest can be visualized directly. Transparency of these fish embryos allows the evaluation of the cellular fate and response to ectopically expressed genes by time-lapse analyses. The combination with inducible promoters permits temporal control of effector gene expression and enables the modulation of the response intensity by adjusting the duration of the heat-shock treatment. This inducible system can be used in transient experiments to study the behavior of transgene expressing cells in an otherwise wild type environment. The combination with the MN and SB system offers to tailor a range of different levels of mosaicism (Fig. 1F,1G,1H,1I,1J,1K). A transgenic Gal4/Vp16 activator line was generated, which provides a powerful tool to induce activator and effector gene expression in a ubiquitous manner at a given time-point (Fig. 1E,1E'). When used in microinjection approaches of reporter vectors containing IR/DRs, our transgenic activator line allows ubiquitous and uniform expression of the reporter gene without the need to generate transgenic effector (UAS) lines (Fig. 2B,2C,2D,2E,2F,2G,2H,2I,2J). In addition to temporal control mediated by the heat-shock promoter, induction using a focused laser-beam  could provide precise spatial control of the effector gene expression.
A YFP/SV40pA cassette was cloned downstream of a 4xUAS/dHSP70 element (non responsive to heat-shock; kind gift of M. Gonzalez-Gaitan). This entire cassette was cloned into pCG1.1 containing the IR/DR sequences of the SB transposable element  resulting in a 5.1 kb plasmid containing the reporter cassette (4xUAS/dHSP70/YFP/SV40pA) and the pBSII backbone flanked by a left and right IR/DR of SB (Fig. 1).
A 1.5 kb zebrafish HSP70 promoter fragment  was subcloned upstream of Gal4/Vp16/SV40pA. The entire cassette was further subcloned into pCG3.0C (containing CFP instead of YFP, see above) resulting in a 8.7 kb plasmid (pCG5.0C) containing the expression cassettes zfHSP70/Gal4/Vp16/SV40pA followed by 4xUAS/CFP/SV40pA flanked by the IR/DRs of SB. Finally, the expression cassettes including the inverted repeats were cloned into a I-SceI backbone vector  and verified by sequencing (Fig. 1).
The 1.5 kb zfHSP70 promoter fragment in pCG5.0WCS was replaced by a truncated zfHSP70 promoter fragment lacking 900 bp 5' to the internal BamHI site resulting in a 7.8 kb plasmid that was verified by sequencing (Fig. 1). Further structural details of the activator and reporter vectors are available upon request.
A Gal4/Vp16 fusion construct (Gal4 DNA binding domain: amino acids (aa) 1–147 and Vp16 transactivation domain: aa 411–491) was designed from Clontech vectors pM (Gal4) and pM3-VP16 (Vp16) and cloned into pCS2+ .
Gal4/Vp16 mRNA was transcribed in vitro from pCGGal4/Vp16 using the mMessage mMachine kit (Ambion Inc.).
Microinjection and heat-shock treatment of medaka embryos
For microinjections, one-cell stage embryos of the Cab inbred strain were used. Microinjection capillaries were backfilled with the injection solution [DNA (5–150 ng/μl); Yamamoto buffer (1×) or DNA (5 ng/μl); Yamamoto buffer (0.5×); I-SceI buffer (0.5×, New England Biolabs); I-SceI meganuclease (0.35 u/μl, New England Biolabs) with or without Gal4/Vp16 mRNA (3.5–50 ng/μl)]. DNA was prepared using a Qiagen Maxiprep kit (Qiagen, USA) and dialyzed using nitrocellulose filters (#VSW01300; Millipore, USA). DNA was injected through the chorion into the cytoplasm of one-cell stage embryos. Heat-shock treatment was performed in small volumes (100–200 μl) using a waterbath at 37°C. Animals used in the study were kept according to national and international ethical provisions for animal husbandry as implemented at EMBL.
Embryos were observed and scored using a MZFLIII dissecting microscope with a 436/20 nm (EF); 480/40 nm (BF) filter set for CFP, a 510/20 nm (EF); 560/40 nm (BF) filter set for YFP and a 360/40 nm (EF); 420 nm (BF) filter set for UV/Brightfield. The stereomicroscope was equipped with a DC500 digital camera for imaging (Leica Microsystems, Germany).
RNA isolation and RT-PCR
Transgenic embryos were heat-shocked and subsequently kept at 28°C to recover for different periods of time. Total RNA was isolated from individual embryos as described . Total RNA was subjected to reverse transcription (SuperscriptII, Gibco-BRL) using a mixture of random hexamer primers (25 μM, Amersham) and gene specific oligomeres for Gal4/Vp16 (25 μM; 5'-CCACGTCCAAAGCCCCATAC-3') and CFP (25 μM; 5'-GTTCATCCATGCCATGTGTAATCCC-3') in a 20 μl reaction. 2 μl of each RT reaction was used for PCR in a 50 μl reaction. The primer pairs used were Gal4/Vp16up2 (5'-GATAATGTGAATAAAGATGCCGTCA-3') and Gal4/Vp16low2 (5'-CCACGTCCAAAGCCCCATAC-3') to amplify a 420 bp fragment, and CFPup2 (5'-TCAAGGAGGACGGCAACATC-3') and CFPlow2 (5'-GTTCATCCATGCCATGTGTAATCCC-3') to amplify a 320 bp fragment. Amplification of a 580 bp fragment of c-actin was used as an internal control using the intron-spanning primer pair c-actinup2 (5'-GCCGCGACCTTACAGACTACCT-3') and c-actinlow2 (5'-CTGTTTAGAAGCATTTGCGGTGGAC-3'). An initial 1 min. denaturation step at 95°C was followed by an additional denaturation step for 30 sec. at 95°C, annealing for 30 sec. at 60°C and elongation at 72°C for 30 sec. The program was repeated for 30 cycles followed by a final extension step for 5 min. at 72°C.
Carl M, Loosli F, Wittbrodt J: Six3 inactivation reveals its essential role for the formation and patterning of the vertebrate eye. Development. 2002, 129: 4057-4063.
Loosli F, Winkler S, Burgtorf C, Wurmbach E, Ansorge W, Henrich T, Grabher C, Arendt D, Carl M, Krone A, Grzebisz E, Wittbrodt J: Medaka eyeless is the key factor linking retinal dertermination and eye growth. Development. 2001, 128: 4035-4044.
Winkler S, Loosli F, Henrich T, Wakamatsu Y, Wittbrodt J: The conditional medaka mutation eyeless uncouples patterning and morphogenesis of the eye. Development. 2000, 127: 1911-1919.
Brand AH, Perrimon N: Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993, 118: 401-415.
Fischer JA, Giniger E, Maniatis T, Ptashne M: GAL4 activates transcription in Drosophila. Nature. 1988, 332: 853-856. 10.1038/332853a0.
Scheer N, Campos-Ortega JA: Use of the Gal4-UAS technique for targeted gene expression in the zebrafish. Mech Dev. 1999, 80: 153-158. 10.1016/S0925-4773(98)00209-3.
Scheer N, Riedl I, Warren JT, Kuwada JY, Campos-Ortega JA: A quantitative analysis of the kinetics of Gal4 activator and effector gene expression in the zebrafish. Mech Dev. 2002, 112: 9-14. 10.1016/S0925-4773(01)00621-9.
Sadowski I, Ma J, Triezenberg S, Ptashne M: GAL4-VP16 is an unusually potent transcriptional activator. Nature. 1988, 335: 563-564. 10.1038/335563a0.
Gill G, Ptashne M: Negative effect of the transcriptional activator GAL4. Nature. 1988, 334: 721-724. 10.1038/334721a0.
Argenton F, Arava Y, Aronheim A, Walker MD: An activation domain of the helix-loop-helix transcription factor E2A shows cell type preference in vivo in microinjected zebra fish embryos. Mol Cell Biol. 1996, 16: 1714-1721.
Köster RW, Fraser SE: Tracing transgene expression in living zebrafish embryos. Developmental Biology. 2001, 233: 329-346. 10.1006/dbio.2001.0242.
Halloran MC, Sato-Maeda M, Warren JT, Su F, Lele Z, Krone PH, Kuwada JY, Shoji W: Laser-induced gene expression in specific cells of transgenic zebrafish. Development. 2000, 127: 1953-1960.
Thermes V, Grabher C, Ristoratore F, Bourrat F, Choulika A, Wittbrodt J, Joly JS: I-SceI meganuclease mediates highly efficient transgenesis in fish. Mech Dev. 2002, 118: 91-98. 10.1016/S0925-4773(02)00218-6.
Ivics Z, Hackett PB, Plasterk RH, Izsvak Z: Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell. 1997, 91: 501-510. 10.1016/S0092-8674(00)80436-5.
Grabher C, Henrich T, Sasado T, Arenz A, Wittbrodt J, Furutani-Seiki M: Transposon-mediated enhancer trapping in medaka. Gene. 2003, 322: 57-66. 10.1016/j.gene.2003.09.009.
Ptashne M: How eukaryotic transcriptional activators work. Nature. 1988, 335: 683-689. 10.1038/335683a0.
Aizawa K, Shimada A, Naruse K, Mitani H, Shima A: The medaka midblastula transition as revealed by the expression of the paternal genome. Gene Expression Patterns. 2003, 3: 43-47. 10.1016/S1567-133X(02)00075-3.
Rupp RAW, Snider L, Weintraub H: Xenopus embryos regulate the nuclear localization of XMyoD. Genes and Development. 1994, 8: 1311-1323.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry. 1987, 162: 156-159. 10.1006/abio.1987.9999.
We thank J. R. Martinez-Moralez and F. Loosli for continuous discussions and helpful suggestions and all members of the Wittbrodt lab for critically reading the manuscript. We thank A. Krone and B. Wittbrodt for technical assistance and E. Grzebisz and A. Nowicka for fish husbandry. This work was supported by grants from the EC and the HFSP (J.W.).
CG designed and performed all experiments and drafted the manuscript. JW conceived of the study, and participated in its design and coordination. All authors read and approved the final manuscript.